A phase II study of a temozolomide-based chemoradiotherapy regimen for high-risk low-grade gliomas: Preliminary results of RTOG 0424.
Barbara Jean Fisher
No relevant relationships to disclose
Jeff Lui
No relevant relationships to disclose
David R. Macdonald
Consultant or Advisory Role - Merck
Honoraria - Merck
Other Remuneration - EMD Serono; Merck; Roche
Glenn Jay Lesser
Consultant or Advisory Role - Merck
Honoraria - Merck
Research Funding - Merck
Stephen Coons
No relevant relationships to disclose
David Brachman
No relevant relationships to disclose
Samuel Ryu
No relevant relationships to disclose
Maria Werner-Wasik
No relevant relationships to disclose
Jean-Paul Bahary
No relevant relationships to disclose
Chen Hu
No relevant relationships to disclose
Minesh P. Mehta
Employment or Leadership Position - Pharmacyclics
Consultant or Advisory Role - Merck
Stock Ownership - Pharmacyclics
Honoraria - Merck